The latest closing stock price for Moleculin Biotech as of November 20, 2024 is 2.67.
An investor who bought $1,000 worth of Moleculin Biotech stock at the IPO in 2016 would have $-996 today, roughly -1 times their original investment - a -50.32% compound annual growth rate over 8 years.
The all-time high Moleculin Biotech stock closing price was 801.00 on June 03, 2016.
The Moleculin Biotech 52-week high stock price is 15.74, which is 489.5% above the current share price.
The Moleculin Biotech 52-week low stock price is 2.12, which is 20.6% below the current share price.
The average Moleculin Biotech stock price for the last 52 weeks is 5.28.
An investor who bought $1,000 worth of Moleculin Biotech stock at the IPO in 2016 would have $-996 today, roughly -1 times their original investment - a -50.32% compound annual growth rate over 8 years.
The all-time high Moleculin Biotech stock closing price was 801.00 on June 03, 2016.
The Moleculin Biotech 52-week high stock price is 15.74, which is 489.5% above the current share price.
The Moleculin Biotech 52-week low stock price is 2.12, which is 20.6% below the current share price.
The average Moleculin Biotech stock price for the last 52 weeks is 5.28.